1.21 USD
↗ 0.03 (2.12%)LIVE (AS OF 10:21 AM EDT)
Milestone Pharmaceuticals Inc. Common Shares
MISTNASDAQ • USD
Market: OPEN
Shares of Milestone Pharmaceuticals Inc. Common Shares (MIST) are trading at $1.21. The stock presents a mixed profile: our models indicate a Buy for technical indicators, while underlying fundamentals flash a Sell. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (224.4%) and a bearish Death Cross on the long-term moving averages. Furthermore, MIST is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Aug 26, 2026.
Open?$1.18
High?$1.25
Low?$1.16
Prev. Close?$1.18
Volume?490.7K
Avg. Volume?1.5M
VWAP?$1.22
Rel. Volume?0.32x
Bid / Ask
Bid?$1.21 × 500
Ask?$1.22 × 1.0K
Spread?$0.01
Midpoint?$1.21
Valuation & Ratios
Market Cap?146.9M
Shares Out?124.5M
Float?113.2M
Float %?90.9%
P/E Ratio?N/A
P/B Ratio?-3.92
EPS?-$0.67
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
Employees
38
Market Cap
146.9M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2019-05-09
Address
1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420
MONTREAL, A8 H4M 2X6
Phone: (514) 336-0444
MONTREAL, A8 H4M 2X6
Phone: (514) 336-0444
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?23
Short Sent.?49
Piotroski F-Score?0/9Weak
Altman Z-Score?-3.70Distress
Confidence?55%Low
Short InterestHigh
Short % of Float?14.70%High
Short Interest?16.6M
Days to Cover?9.4
Free Float113.2M
Avg Daily Volume1.8M
Settlement Date2026-08-14
Financial Health
Current Ratio?8.13Strong
Quick Ratio?7.92Strong
Cash Ratio?7.65Strong
Debt/Equity?-1.58Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-3.92CHEAP▾
S&P97
P/S?62.70HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-0.5CHEAP▾
S&P97
EV/Sales?15.53HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?224.4%STRONG▾
Peers50
S&P97
ROA?-46.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-61646000
Enterprise Value?$36.4M
Fundamentals ratios updated end of day